OncoGenex reports positive results from phase II clinical trial of OGX-011 in prostate cancer Dec. 5, 2008
Nur77-derived peptide acts as converter of Bcl-2 receptor inducing apoptosis of cancer cells Dec. 5, 2008
FDA grants approval to PharmaEngine's IND for phase II study of PEP-02 in pancreatic cancer Dec. 4, 2008
RSS